FDA inspection

Bioreliance Ltd.: FDA inspection ending Oct 10, 2017

FDA inspection 1066803 · Voluntary Action Indicated (VAI) · Stirling, Scotland

Key facts

Inspection ID 1066803
Firm Bioreliance Ltd.
FEI number 3005619549
Address Hillfoots Road, SCOTLAND; INNOVATION PARK
City Stirling, Scotland
Country United Kingdom
Fiscal year 2018
Inspection end date Oct 10, 2017
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections